Investigational Use of Neuromuscular Ultrasound
Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Feb 11, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of ultrasound, a technique that uses sound waves to create images, to better understand the health and function of nerves and muscles in people with various conditions like muscular dystrophy, peripheral neuropathy, and motor neuron disorders. The goal is to improve how we can observe and measure the function of these vital systems, which is important for diagnosing and treating nerve and muscle disorders.
To participate, you need to be an adult aged 18 or older. Healthy individuals are welcome, as well as those who have a neuromuscular disorder or show symptoms of one. Participants will attend up to five outpatient visits, where they will provide a medical history, undergo a physical exam, and have ultrasounds done on their nerves and muscles. The ultrasound involves applying gel to the skin and using a small probe that sends sound waves to create pictures. Some participants may also have nerve conduction studies, which involve placing small wires on the skin to measure how well nerves work. Overall, this study aims to gather important information while ensuring a comfortable and informative experience for participants.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- • 1. Healthy Volunteers-Adults
- • 1. Healthy adults, male or female, aged 18 years old or older,
- • 2. In good general health as evidenced by medical history, medical conditions under control such as hypertension acceptable.
- • 3. Stated willingness to comply with all study procedures and availability for the duration of the study.
- • 4. Ability of subject to understand and the willingness to sign a written informed consent document.
- • 2. Participants with neuromuscular disorders
- • 1. Adults, male or female, aged 18 years old or older,
- • 2. Diagnosed with a neuromuscular disorder or have signs and symptoms of nerve or muscle disorder or neuromuscular diaphragm dysfunction.
- • 3. Stated willingness to comply with all study procedures and availability for the duration of the study.
- • 4. Ability of subject to understand and the willingness to sign a written informed consent document.
- EXCLUSION CRITERIA:
- • 1. Healthy Volunteers-Adults
- • History of stroke, muscle disorders, peripheral neuropathy, or spine surgery
- • 2. Participants with neuromuscular disorders
- • No clinical evidence of a neuromuscular disorder on clinical evaluation.
About National Institute Of Neurological Disorders And Stroke (Ninds)
The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
Tanya J Lehky, M.D.
Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials